Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,871
Closed -$652K 1255
2021
Q4
$983K Buy
3,871
+71
+2% +$20.8K 0.03% 434
2021
Q3
$1.46M Buy
+3,800
New +$1.4M 0.06% 319
2021
Q1
Sell
-19,884
Closed -$2.88M 1022
2020
Q4
$2.08M Buy
19,884
+16,784
+541% +$1.7M 0.08% 188
2020
Q3
$219K Sell
3,100
-50,484
-94% -$3.52M 0.01% 560
2020
Q2
$3.44M Buy
53,584
+43,358
+424% +$2.37M 0.19% 118
2020
Q1
$306K Buy
+10,226
New +$235K 0.02% 372

Other funds holding MRNA

CSS LLC's MRNA Position: Q1 2022 in Review

CSS LLC sold out of Moderna (MRNA) in Q1 2022, closing a stake of 3,871 shares — an estimated $652K sold.

CSS LLC first reported a position in MRNA in Q1 2020 and held it in 6 quarters. The position peaked at $3.44M in Q2 2020. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • CSS LLC reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • CSS LLC sold 3,871 Moderna shares in Q1 2022, an estimated $652K.
  • CSS LLC first reported a position in Moderna in Q1 2020 and held it in 6 quarters.
  • CSS LLC's Moderna position peaked at $3.44M in Q2 2020.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.